Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation

Circulation

Volumn 87, Issue 1, 1993, Pages 261-269

  Eich, David M ^a   Nestler, John E ^b   Johnson, Danna E ^b   Dworkin, Gary H ^b   Ko, Daijin ^b   Wechsler, Andrew S ^b   Hess, Michael L ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Atherosclerosis, cardiac; Dehydroepiandrosterone; Hypercholesterolemia; Transplantation, cardiac

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EFFECT; FEEDING; HEART TRANSPLANTATION; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; LIPID BLOOD LEVEL; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; RANDOMIZATION; RISK FACTOR; XENOTRANSPLANTATION;

ANIMAL; CORONARY ARTERIOSCLEROSIS; HEART TRANSPLANTATION; HYPERCHOLESTEROLEMIA; MALE; MYOCARDIUM; POSTOPERATIVE COMPLICATIONS; PRASTERONE; RABBITS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HETEROTOPIC;

EID: 0027388918     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.87.1.261     Document Type: Article

References (37)

1. Barnhart GR, Pascoe EA, Mills AS, Szentpetery S, Eich DM, Mohanakumar T, Hastillo A, Thompson JA, Hess ML, Lower RR: Accelerated coronary arteriosclerosis in cardiac transplant recipients. Transplant Review 1987;1:31-46
2. Hess ML, Hastillo A, Mohanakumar T, Cowley MJ, Vetrovec G, Szentpetery S, Wolfgang TC, Lower RR: Accelerated atherosclerosis in cardiac transplantation: Role for cytotoxic B-cell antibodies and hyperlipidemia. Circulation 1982;68(suppl II):II-94-II-101
3. Eich DM, Thompson JA, Ko D, Hastillo A, Lower RR, Katz SR, Katz M, Hess ML: Hypercholesterolemia in long-term survivors of cardiac transplantation: An early marker of accelerated coronary disease. J Heart Transplant 1991;10:45-49
4. Alonzo DR, Starek PK, Minnick CR: Studies on the pathogenesis of ather-arteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am J Pathol 1977;87:415-422
5. Nestler JE, Barlascini CO, Clore JN, Blackard WG: Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988;66:57-61
6. Barrett-Connor E, Khan KT, Yen SSC: A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986;315:1519-1528
7. Slowinska-Srzednicka J, Zglicznski S, Ciswicka-Sznajderman M, Szrednicki M, Soszynski P, Biernacka M, Woroszylska M, Ruzyllo W, Sadowski Z: Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis 1989;79:197-203
8. Gordon GB, Bush DE, Weisman HF: Reduction of atherosclerosis by administration of dehydroepiandrosterone. J Clin Invest 1988; 82:712-720
9. Arad Y, Badimon JO, Badimon L, Hembrec W, Ginsberg HN: Dehydroepiandrosterone feeding prevents aortic fatty stream formation and cholesterol accumulation in cholesterol-fed rabbits. Arteriosclerosis 1989;9:159-166
10. Dworkin GH, Eich DM, Allen C, Wechsler AS: A revised technique of heterotopic heart transplantation in rabbits. J Heart Transplant 1991;10:591-599
11. Billingham ME: Diagnosis of cardiac rejection by endomyocardial biopsy. J Heart Lung Transplant 1981;1:25-30
12. Rousseuw PJ: Least median of squares regression. J Am Stat Assoc 1984;79:871-880
13. Rousseuw P, Leroy A: Robust regression and outlier detection. New York, John Wiley & Sons, Inc, 1987
14. Orentreich N, Brind JL, Rizer RL, Vogelman JH: Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59: 551-555
15. Migeon CJ, Keller AR, Lawrence B, Shepard TH II: Dehydroepiandrosterone and androsterone levels in human plasma. J Clin Endocrinol Melab 1957;17:1051-1062
16. vy/a mice by dehydroepiandrosterone. Lipids 1977;12:409-413
17. Schwartz AG, Hard GC, Pashko LL, Abou-Gharbia M, Swern D: Dehydroepiandrosterone: An anti-obesity and anti-cardiogenic agent. Nutrition 1981;3:46-53
18. Cleary MP, Shepherd A, Jenks B: Effect of dehydroepiandrosterone on growth in lean and obese Zucker rats. J Nutr 1984;114: 1242-1251
19. Shepherd A, Cleary MP: Metabolic alterations after dehydroepiandrosterone treatment in Zucker rats. Am J Physiol 1984;246: E123-E128
20. Cleary MP, Fox N, Lazin B, Billheimer JT: A comparison of the effects of dehydroepiandrosterone treatment to ad libitum and pair-feeding in the obese Zucker rat. Nutr Res 1985;5:1247-1257
21. Ben-David M, Dikstein S, Bismuth G, Sulman FG: Antihypercholesterolemic effect of dehydroepiandrosterone in rats. Proc Soc Exp Biol Med 1967;125:1136-1140
22. Kurzman ID, MacEwen EG, Haffa ALM: Reduction in body weight and cholesterol in spontaneously obese dogs by dehydroepiandrosterone. Int J Obes 1990;14:95-104
23. Coleman DL, Leiter EH, Schwizer RW: Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 1982; 31:830-833
24. Coleman DL, Leiter EH, Applezweig N: Therapeutic effects of dehydroepiandrosterone metabolites in diabetes mutant mice (C57BL/KsJ-dbdb). Endocrinology 1984;115:239-243
25. Coleman DL, Schwizer RW, Leiter EH: Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice. Diabetes 1984;33:26-32
26. vy), and normal mice. Endocrinology 1985; 117:2279-2283
27. Herrington DM, Gordon GB, Achuff SC, Trejo JF, Weisman HF, Kwiterovich PO, Pearson TA: Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 1990;16:862-870
28. 3H)DHEA binding in rat liver. Biochem Biophys Res Commun 1988;156:22-29
29. Leiter EH, Beamer WG, Coleman DL, Longcope C: Androgenic and estrogenic metabolites in serum of mice fed dehydroepiandrosterone: Relationship to antihyperglycemic effects. Metabolism 1987;36:863-869
30. Foegh ML, Khirabadi BS, Nakanishi T, Vargas R, Ramwell PW: Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc 1987;19(suppl 5):90-95
31. Dworkin CR, Gorman SD, Pashko LL, Christofalo VJ, Schwartz AG: Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo- and deoxyribonucleosides. Life Sci 1986;38:1451-1457
32. Lucas JA, Ahmed SA, Casey LM, MacDonald PC: Prevention of autoantibody formation and prolonged survival in New Zealand : Black/New Zealand White F, mice fed dehydroepiandrosterone. J Clin Invest 1985;75:2091-2093
33. Loria RM, Inge TH, Cook SS, Szakal AK, Regelson W: Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J Med Virol 1988;26:301-314
34. Jesse R, Nestler J, Eich D, Hess M: Dehydroepiandrosterone in vivo and in vitro inhibits platelet aggregation. (abstract) J Am Coll Cardiol 1991;17(suppl A):376A
35. 3. Biochem Biophys Acta 1989;1014:90-97
36. Whitcomb JM, Schwartz AG: Dehydroepiandrosterone and 16α-Br-epiandrosterone inhibit 12-0-tetradecanoylphorbol-13-acetate stimulation of superoxide radical production by human polymorphonuclear leukocytes. Carcinogenesis (Lond) 1985;6:333-335
37. Oertel GW, Benes P: The effects of steroids on glucose-6-phosphate dehydrogenase. J Steroid Biochem 1972;3:493-496